Sustained metabolic response in metastatic melanoma after intraperitoneal ozone therapy: a case report
{{output}}
Background: Metastatic melanoma remains a therapeutic challenge despite major advances in immunotherapy and targeted therapies. Immune checkpoint inhibitors and BRAF/MEK inhibitors have improved survival in selected patients; how... ...
